The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(8-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)acetonitrile ID: ALA3928698
PubChem CID: 134141902
Max Phase: Preclinical
Molecular Formula: C22H14N4S
Molecular Weight: 366.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#CCc1ccc(-n2cnc3cnc4ccc(-c5ccsc5)cc4c32)cc1
Standard InChI: InChI=1S/C22H14N4S/c23-9-7-15-1-4-18(5-2-15)26-14-25-21-12-24-20-6-3-16(11-19(20)22(21)26)17-8-10-27-13-17/h1-6,8,10-14H,7H2
Standard InChI Key: LAPRMRQFLNUIQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
1.3028 -1.8283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0079 -1.4195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7165 -1.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7173 -2.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4258 -3.0508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1341 -2.6400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1293 -1.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4202 -1.4145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0097 -3.0568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3003 -2.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6890 -3.1920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0207 -3.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8369 -3.8589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3807 -4.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1245 -5.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6689 -5.8506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4696 -5.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7231 -4.9018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1770 -4.2967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0156 -6.2912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7621 -7.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5091 -7.8432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8435 -3.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9321 -3.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7321 -4.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1380 -3.3178 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.5887 -2.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 10 2 0
9 4 2 0
3 2 2 0
2 1 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 14 1 0
17 20 1 0
20 21 1 0
21 22 3 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 23 2 0
6 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 366.45Molecular Weight (Monoisotopic): 366.0939AlogP: 5.37#Rotatable Bonds: 3Polar Surface Area: 54.50Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.87CX Basic pKa: 2.77CX LogP: 4.42CX LogD: 4.42Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.43Np Likeness Score: -1.55
References 1. Glatthar R, Stojanovic A, Troxler T, Mattes H, Möbitz H, Beerli R, Blanz J, Gassmann E, Drückes P, Fendrich G, Gutmann S, Martiny-Baron G, Spence F, Hornfeld J, Peel JE, Sparrer H.. (2016) Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors., 59 (16): [PMID:27502541 ] [10.1021/acs.jmedchem.6b00598 ]